BioSpace News Archive

Business

Candel Therapeutics Appoints Diem Nguyen, Ph.D., M.B.A., to Its Board of Directors

Candel Therapeutics, Inc. today announced it has appointed Diem Nguyen, Ph.D., M.B.A., to its Board of Directors.

July 15, 2021
·
3 min read
Vivasure Medical Announces Development of Sutureless Venous Closure Device for Use in Percutaneous Transcatheter Procedures

Vivasure Medical today announced its development program for PerQseal ® Blue, the company’s new investigational product.

July 15, 2021
·
3 min read
Genetown

CANbridge Pharmaceuticals CAN106 Investigational New Drug Application Approved in China for the Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)

CANbridge Pharmaceuticals Inc. announced that the Chinese National Medical Products Administration (NMPA) has approved an Investigational New Drug (IND) application for CAN106, a long-acting humanized monoclonal antibody targeting complement C5 of the complement system.

July 15, 2021
·
3 min read
Business

GentiBio and Forge Biologics Announce Viral Vector Contract Development and GMP Manufacturing Partnership

GentiBio, Inc. announced a strategic development and manufacturing partnership today to advance GentiBio’s unique immune tolerance platform.

July 15, 2021
·
4 min read
Business

Viz.ai and Avicenna.AI Partner to Launch World-class AI-Driven Intelligent Care Coordination for Pulmonary Embolism and Aortic Disease

Viz.ai, the world leader in AI-driven intelligent care coordination, has partnered with Avicenna.AI, a global leader in artificial intelligence solutions, to enable intelligent care coordination and improve patient triage of patients suffering from pulmonary embolism (PE) and aortic disease

July 15, 2021
·
4 min read
Drug Development

Bio-Thera Solutions Announces the First Patient Dosed in Phase III Clinical Trial for BAT2206, a Proposed Biosimilar of Stelara® (Ustekinumab)

Bio-Thera Solutions, Ltd. today announced that the first patient has been dosed in a Phase III clinical study for BAT2206, a proposed biosimilar of Stelara® (ustekinumab).

July 15, 2021
·
4 min read
NLS Pharmaceutics Announces FDA Acceptance of IND Application to Initiate Clinical Trials with Quilience(R) (mazindol ER) to Treat Narcolepsy

NLS Pharmaceutics Ltd. announces that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug application

July 15, 2021
·
4 min read
Lone Star Bio

The Ingredient Transparency Center’s Collagen Stewardship Alliance Adds BioCell Technology to its Supporter List

Today, the Ingredient Transparency Center’s Collagen Stewardship Alliance (CSA) announced that BioCell Technology, LLC has signed on as a Sponsor Level supporter.

July 15, 2021
·
3 min read
Business

ImmunoPrecise to Report Financial Results and Business Highlights for Fiscal Year 2021

IMMUNOPRECISE ANTIBODIES LTD. today announced the Company will host a conference call to discuss its financial results and business highlights for the full fiscal year 2021.

July 15, 2021
·
2 min read
Drug Development

Vir Biotechnology Initiates Phase 2 Clinical Trial Evaluating the Combination of VIR-2218 and VIR-3434 as a Functional Cure Regimen for Chronic Hepatitis B Virus Infection

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the first patient has been dosed in the Phase 2 MARCH trial evaluating VIR-2218 together with VIR-3434 for the treatment of patients with chronic hepatitis B virus (HBV) infection.

July 15, 2021
·
5 min read